acetabular dysplasia
Conditions
Interventions
Intravenous tranexamic acid 1000mg at the time of incision
Intravenous tranexamic acid 1000mg at the time of incision and 1000mg at the time of closure
control subjects
Sponsors
Fukuoka University,Dept.of Orthop.Surg
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: acetabular dysplasia over twenty years of age
Exclusion criteria
Exclusion criteria: A history of VTE , renal dysfunction, use of hormone replacement therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total Blood loss | — |
Countries
Japan
Contacts
Public ContactAyumi Matsunaga
Fukuoka University Dept.of Orthop.Surg
Outcome results
None listed